Company Search:
Advanced Search
Sponsored Links
Protek OAO (P) Company Snapshot
Protek OAO (P) operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Protek OAO (P) with three other pharmaceutical manufacturers in Europe: Lonza Group AG of Switzerland (2015 sales of 3.80 billion Swiss Francs [US$3.84 billion] of which 57% was Specialty Ingredients), Meda Ab of Sweden (19.65 billion Swedish Kronor [US$2.23 billion] of which 62% was RX), and Stada Arzneimittel AG which is based in Germany (2.12 billion Euro [US$2.32 billion] of which 58% was Generics).

Sales Analysis. During the year ended December of 2015, sales at Protek OAO (P) were 195.31 billion Russian Rubles (US$3.12 billion). This is an increase of 24.4% versus 2014, when the company's sales were 156.95 billion Russian Rubles. This was the fifth consecutive year of sales increases at Protek OAO (P) (and since 2010, sales have increased a total of 96%). Sales of Distribution saw an increase of 24.7% in 2015, from 127.46 billion Russian Rubles to 158.94 billion Russian Rubles.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Protek OAO (P)
  Stock Performance Chart for Protek OAO (P)
  Stock Data: Recent Stock Performance:
  Current Price (10/14/2016): 91.60
(Figures in Russian Rubles)
1 Week 1.4%   13 Weeks 2.8%  
4 Weeks 8.9%   52 Weeks 97.0%  
Protek OAO (P) Key Data:
  Ticker: PRTK Country: Russian Federation
  Exchanges: RTS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 195,308,866,000
(Year Ending Jan 2016).
Employees: 11,800
  Currency: Russian Rubles Market Cap: 48,286,285,701
  Fiscal Yr Ends: December Shares Outstanding: 527,142,857
  Share Type: Closely Held Shares: 392,302,350
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.